BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dhritlahre RK, Saneja A. Recent advances in HER2-targeted delivery for cancer therapy. Drug Discov Today 2021;26:1319-29. [PMID: 33359114 DOI: 10.1016/j.drudis.2020.12.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang B, Liu W, Li M, Mo J. GSK-J1-loaded, hyaluronic acid-decorated metal-organic frameworks for the treatment of ovarian cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1023719] [Reference Citation Analysis]
2 Chupradit S, Widjaja G, Radhi Majeed B, Kuznetsova M, Ansari MJ, Suksatan W, Turki Jalil A, Ghazi Esfahani B. Recent advances in cold atmospheric plasma (CAP) for breast cancer therapy. Cell Biology International 2022. [DOI: 10.1002/cbin.11939] [Reference Citation Analysis]
3 Jia D, Liu H, Zheng S, Yuan D, Sun R, Wang F, Li Y, Li H, Yuan F, Fan Q, Zhao Z. ICG-Dimeric Her2-Specific Affibody Conjugates for Tumor Imaging and Photothermal Therapy for Her2-Positive Tumors. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00708] [Reference Citation Analysis]
4 Guo J, Huang L. Nanodelivery of cGAS-STING activators for tumor immunotherapy. Trends Pharmacol Sci 2022:S0165-6147(22)00177-8. [PMID: 36089410 DOI: 10.1016/j.tips.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen L, Chen F, Niu H, Li J, Pu Y, Yang C, Wang Y, Huang R, Li K, Lei Y, Huang Y. Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities. Front Immunol 2022;13:871661. [DOI: 10.3389/fimmu.2022.871661] [Reference Citation Analysis]
6 Eras A, Castillo D, Suárez M, Vispo NS, Albericio F, Rodriguez H. Chemical Conjugation in Drug Delivery Systems. Front Chem 2022;10:889083. [DOI: 10.3389/fchem.2022.889083] [Reference Citation Analysis]
7 Khan N, Ruchika, Kumar Dhritlahre R, Saneja A. Recent advances in dual-ligand targeted nanocarriers for cancer therapy. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Motamed Fath P, Rahimnejad M, Moradi-kalbolandi S, Ebrahimi Hosseinzadeh B, Jamshidnejad-tosaramandani T. Improvement of cytotoxicity and necrosis activity of ganoderic acid a through the development of PMBN-A.Her2-GA as a targeted nano system. RSC Adv 2021;12:1228-37. [DOI: 10.1039/d1ra06488f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhou J, Zou Y, Cai Y, Chi F, Huang W, Shi W, Qian H. A designed cyclic peptide based on Trastuzumab used to construct peptide-drug conjugates for its HER2-targeting ability. Bioorg Chem 2021;117:105453. [PMID: 34736138 DOI: 10.1016/j.bioorg.2021.105453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jia L, Zhang P, Sun H, Dai Y, Liang S, Bai X, Feng L. Optimization of Nanoparticles for Smart Drug Delivery: A Review. Nanomaterials (Basel) 2021;11:2790. [PMID: 34835553 DOI: 10.3390/nano11112790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Wawruszak A, Halasa M, Okon E, Kukula-Koch W, Stepulak A. Valproic Acid and Breast Cancer: State of the Art in 2021. Cancers (Basel) 2021;13:3409. [PMID: 34298623 DOI: 10.3390/cancers13143409] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
12 Nieto C, Vega MA, Martín Del Valle E. Nature-Inspired Nanoparticles as Paclitaxel Targeted Carrier for the Treatment of HER2-Positive Breast Cancer. Cancers (Basel) 2021;13:2526. [PMID: 34064007 DOI: 10.3390/cancers13112526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Raza M, Kumar N, Nair U, Luthra G, Bhattacharyya U, Jayasundar S, Jayasundar R, Sehrawat S. Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy. Mol Cell Biochem 2021;476:3271-84. [PMID: 33886058 DOI: 10.1007/s11010-021-04149-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Naik GG, Shah J, Balasubramaniam AK, Sahu AN. Applications of natural product-derived carbon dots in cancer biology. Nanomedicine (Lond) 2021;16:587-608. [PMID: 33660530 DOI: 10.2217/nnm-2020-0424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]